BEAT

시간 외 거래: 2.61 -0.02 -0.76%

Heartbeam Inc (BEAT)

개요 뉴스 가격 이력 Financials 토론 예측

Relative Volume:

Heartbeam Inc Stock (BEAT) Company Profile

Heartbeam Inc

Healthcare (1128)

408-899-4443

2118 WALSH AVE., SUITE 210, SANTA CLARA

최신 SEC 제출 서류

BEAT's Discussions on Twitter

BEAT을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
BEAT Heartbeam Inc	2.63	79.22M	0	-20.34M	-15.59M	-0.697
VEEV Veeva Systems Inc	220.10	36.70B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	68.67	12.56B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	44.65	8.26B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	95.75	8.27B	1.15B	96.70M	-161.99M	1.09
BTSG Brightspring Health Services Inc	35.96	6.59B	11.99B	24.18M	234.31M	0.2956

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-12-11	업그레이드	The Benchmark Company	Speculative Buy → Buy
2025-12-08	개시	H.C. Wainwright	Buy
2025-10-31	개시	Roth Capital	Buy
2020-09-11	개시	Needham	Buy
2020-09-02	개시	Robert W. Baird	Neutral
2020-01-08	개시	SunTrust	Buy
2019-08-02	다운그레이드	Raymond James	Outperform → Mkt Perform
2019-04-26	재확인	Dougherty & Company	Buy
2018-07-26	재확인	Lake Street	Buy
2018-04-26	재확인	The Benchmark Company	Buy
2018-02-23	재확인	Dougherty & Company	Buy
2017-11-08	재확인	Dougherty & Company	Buy
2017-10-26	개시	Raymond James	Outperform
2017-10-24	개시	SunTrust	Buy
2017-08-09	재확인	Dougherty & Company	Buy
2017-07-19	재확인	The Benchmark Company	Buy
2017-04-11	재확인	Dougherty & Company	Buy
2016-12-02	개시	Dougherty & Company	Buy
2016-09-13	개시	Sidoti	Buy
2016-08-03	재확인	The Benchmark Company	Buy
2015-07-28	재확인	Dougherty & Company	Buy
2013-10-24	개시	The Benchmark Company	Buy
2013-08-21	개시	Dougherty & Company	Buy

Heartbeam Inc 주식(BEAT)의 최신 뉴스

Heartbeam Inc (BEAT) 재무 분석

Heartbeam Inc (BEAT)

Heartbeam Inc Stock (BEAT) Company Profile

BEAT을(를) 다른 주식과 비교

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Heartbeam Inc 주식(BEAT)의 최신 뉴스

HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN

HeartBeam Stock 7-Day Winning Spree: Stock Climbs 227% - Trefis

Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com

HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com

HeartBeam Stock Soars: Should You Buy? - timothysykes.com

Heartbeam stock is a buy, this analyst says - Cantech Letter

HeartBeam Stock Surges 201%, With A 6-Day Winning Spree - Trefis

Benchmark Upgrades HeartBeam (BEAT) - Nasdaq

BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System - sharewise.com

HeartBeam updates regulatory strategy for 12-lead ECG Synthesis Software - MSN

HeartBeam Stock Surges: Analyzing the Uptrend - StocksToTrade

Why Is Micro Cap HeartBeam Stock Surging On Wednesday? - Sahm

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

HeartBeam swells on turning FDA rejection into ECG clearance - Fierce Biotech

symbol__ Stock Quote Price and Forecast - CNN

3 Penny Stocks to Watch Now, 12/11/25 - TipRanks

Why did BEAT stock rocket 72% in pre-market today? - MSN

HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free 12-lead ECG - Cardiac Rhythm News

HeartBeam (BEAT) Receives Upgrade from Benchmark Analyst | BEAT Stock News - GuruFocus

HeartBeam go-to-market strategy remains on track, says Benchmark - TipRanks

HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance - Investing.com India

HeartBeam sinks after ‘Not Substantially Equivalent’ letter from FDA - MSN

HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views - ts2.tech

Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025) - ts2.tech

5-Day Rally Sends HeartBeam Stock Up 120% - Trefis

HeartBeam Receives FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz

HeartBeam announces FDA clearance for 12-lead ECG synthesis software - MSN

Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

HC Wainwright & Co. Maintains HeartBeam (BEAT) Buy Recommendation - Nasdaq

Heartbeam wins appeal, gains FDA clearance - BioWorld MedTech

FDA Greenlight Sends HeartBeam, Photronics, And Designer Brands Shares Climbing - Finimize

HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - Yahoo Finance

HeartBeam’s Leap: Should Investors Be Wary? - StocksToTrade

FDA Clears HeartBeam Cable-free 12-lead ECG - respiratory-therapy.com

HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz

HeartBeam (BEAT) Stock: Surges 50% After FDA Grants Clearance For its 12-lead ECG Device - parameter.io

HeartBeam (BEAT) Analyst Rating: HC Wainwright Raises Price Targ - GuruFocus

HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright - TipRanks

FDA clears HeartBeam’s at-home arrhythmia assessment tool - Yahoo

Weekly Trades: Is HeartBeam Inc stock recession proofTrade Entry Report & Community Trade Idea Sharing Platform - BỘ NỘI VỤ

HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - TipRanks

HeartBeam Receives FDA Clearance for 12-Lead ECG for At-Home Arrhythmia Assessment - marketscreener.com

HeartBeam Wins FDA Nod for Cable-Free 12-Lead ECG for Home Arrhythmia Assessment - Medical Product Outsourcing

HeartBeam Shares Surge: Buy Signal? - timothysykes.com

HeartBeam : Earnings Documents - marketscreener.com

HeartBeam stock soars after FDA clearance for 12-lead ECG synthesis software - Investing.com Nigeria

Why Is HeartBeam Stock (BEAT) Up Today? - TipRanks

Heartbeam rises after FDA clears its cable‑free ECG software - TradingView — Track All Markets

HeartBeam’s 12-lead ECG synthesis software receives FDA clearance By Investing.com - Investing.com Australia

HeartBeam’s 12-lead ECG synthesis software receives FDA clearance - Investing.com India

Heartbeam Inc (BEAT) 재무 분석

매출

순이익

현금흐름

주당 순 이익

BEAT과 유사한 종목